Fas counter-attack - the best form of tumor defense?

被引：56

作者：

O'Connell, J ^{[1
]}

Bennett, MW

O'Sullivan, GC

Collins, JK

Shanahan, F

机构：

[1] Natl Univ Ireland Univ Coll Cork, Univ Hosp, Dept Med, Cork, Ireland

[2] Natl Univ Ireland Univ Coll Cork, Mercy Hosp, Dept Surg, Cork, Ireland

来源：

NATURE MEDICINE | 1999年 / 5卷 / 03期

关键词：

D O I：

10.1038/6477

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

New in vivo evidence confirms that tumor-expressed Fas ligand impairs immune responses to cancer by inducing apoptosis of anti-tumor immune effector cells.

引用

页码：267 / 268

页数：2

共 13 条

[1] Bennett MW, 1998, J IMMUNOL, V160, P5669
[2] Cardi G, 1998, CANCER RES, V58, P2078
[3] Regulation of the proinflammatory effects of Fas ligand (CD95L)
Chen, JJ
Sun, YN
Nabel, GJ
[J]. SCIENCE, 1998, 282 (5394) : 1714 - 1717
[4] Daniel PT, 1997, J IMMUNOL, V159, P3808
[5] CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance
Griffith, TS
Yu, XH
Herndon, JM
Green, DR
Ferguson, TA
[J]. IMMUNITY, 1996, 5 (01) : 7 - 16
[6] Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape
Hahne, M
Rimoldi, D
Schroter, M
Romero, P
Schreier, M
French, LE
Schneider, P
Bornand, T
Fontana, A
Lienard, D
Cerottini, JC
Tschopp, J
[J]. SCIENCE, 1996, 274 (5291) : 1363 - 1366
[7] Depletion of the natural killer cell population in the peritoneum by AK-5 tumor cells overexpressing Fas-ligand: A mechanism of immune evasion
Khar, A
Varalakshmi, C
Pardhasaradhi, BVV
Ali, AM
Kumari, AL
[J]. CELLULAR IMMUNOLOGY, 1998, 189 (02) : 85 - 91
[8] Prolonged survival of rat liver allografts transfected with Fas ligand-expressing plasmid
Li, XK
Okuyama, T
Tamura, A
Enosawa, S
Kaneda, Y
Takahara, S
Funashima, N
Yamada, M
Amemiya, H
Suzuki, S
[J]. TRANSPLANTATION, 1998, 66 (11) : 1416 - 1423
[9] Maeda A, 1998, BRIT J DERMATOL, V139, P198
[10] O'Connell J, 1998, J PATHOL, V186, P240

← 1 2 →